Searching for Synergy: FAK Inhibition in Metastatic Breast Cancer Treatment
Breast cancer is the most common cancer among Canadian women and 14-20% will develop lethal metastases within 5 years. A potential novel therapeutic target is Focal Adhesion Kinase (FAK), a cytoplasmic tyrosine kinase. FAK’s expression is inversely correlated with survival and is known to regulate c...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/37304 http://dx.doi.org/10.20381/ruor-21576 |